Unigene Laboratories, Inc. (UGNE) Announces Novartis Pharma AG (NVS)' Disclosure of First Interpretable Results from Phase 3 Trial of Calcitonin (SMC021) in the Treatment of Post-menopausal Osteoporosis
11/14/2011 7:08:13 AM
More...
|
Novartis Pharma AG (NVS) Selects Veeva Systems, Inc. CRM for Global Deployments
10/19/2010 10:41:35 AM
More...
|
Emisphere Technologies, Inc. (EMIS), Novartis Pharma AG (NVS). Nordic Bioscience A/S Provide Update on Osteoarthritis Phase III Study With Oral Calcitonin; Drug Deemed Safe But Not Effective, Emisphere Stock Falls 61.15% at 1:37PM EDT
7/23/2010 7:08:08 AM
More...
|
Emisphere Technologies, Inc. (EMIS) Announces Expanded Collaboration Agreement With Novartis Pharma AG (NVS) and Cancellation of Convertible Promissory Note
6/4/2010 9:58:37 AM
More...
|
Titan Pharmaceuticals (TTP) Provides Estimate of Upcoming Royalty Payment
4/22/2010 10:51:38 AM
More...
|
Emisphere Technologies, Inc. (EMIS) Partner Initiates Second Phase I Trial for Oral PTH Therapy for the Treatment of Postmenopausal Osteoporosis
4/15/2010 9:55:23 AM
More...
|
Novartis Pharma AG (NVS) Reports Positive Results From Phase II LCZ696 Trial
3/17/2010 9:00:25 AM
More...
|
Emisphere Technologies, Inc. (EMIS) Announces Extension of Maturity Date for Novartis Pharma AG (NVS) Convertible Promissory Note
11/30/2009 9:11:56 AM
More...
|
Idenix Pharmaceuticals, Inc. (IDIX) Says Novartis Pharma AG (NVS) (JOBS) Not to License Hepatitis C Drug
10/30/2009 6:32:45 AM
More...
|
QLT Inc. (QLTI) Gets Rights to Sell Visudyne in US from Novartis Pharma AG (NVS) (JOBS)
10/19/2009 6:23:07 AM
More...
|
|